203 related articles for article (PubMed ID: 37886874)
1. Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.
Liu YL; Gordhandas S; Arora K; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Salo-Mullen E; Zhou Q; Iasonos A; Carrot-Zhang J; Manning-Geist B; Sia TY; Selenica P; Vanderbilt C; Misyura M; Latham A; Bandlamudi C; Berger MF; Hamilton JG; Makker V; Abu-Rustum NR; Ellenson LH; Offit K; Mandelker DL; Stadler Z; Weigelt B; Aghajanian C; Brown C
Cancer; 2024 Feb; 130(4):576-587. PubMed ID: 37886874
[TBL] [Abstract][Full Text] [Related]
2. Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Liu YL; Maio A; Kemel Y; Salo-Mullen EE; Sheehan M; Tejada PR; Trottier M; Arnold AG; Fleischut MH; Latham A; Carlo MI; Murciano-Goroff YR; Walsh MF; Mandelker D; Mehta N; Bandlamudi C; Arora K; Zehir A; Berger MF; Solit DB; Aghajanian C; Diaz LA; Robson ME; Brown CL; Offit K; Hamilton JG; Stadler ZK
Cancer; 2022 Nov; 128(21):3870-3879. PubMed ID: 36041233
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of germline drivers in endometrial cancer.
Gordhandas S; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Ranganathan M; Green D; Aryamvally A; Arnold AG; Salo-Mullen E; Manning-Geist B; Sia T; Selenica P; Da Cruz Paula A; Vanderbilt C; Misyura M; Leitao MM; Mueller JJ; Makker V; Rubinstein M; Friedman CF; Zhou Q; Iasonos A; Latham A; Carlo MI; Murciano-Goroff YR; Will M; Walsh MF; Issa Bhaloo S; Ellenson LH; Ceyhan-Birsoy O; Berger MF; Robson ME; Abu-Rustum N; Aghajanian C; Offit K; Stadler Z; Weigelt B; Mandelker DL; Liu YL
J Natl Cancer Inst; 2023 May; 115(5):560-569. PubMed ID: 36744932
[TBL] [Abstract][Full Text] [Related]
4. Germline Pathogenic Variants and Genetic Counseling by Ancestry in Patients With Epithelial Ovarian Cancer.
Sia TY; Maio A; Kemel YM; Arora KS; Gordhandas SB; Kahn RM; Salo-Mullen EE; Sheehan MA; Tejada PR; Bandlamudi C; Zhou Q; Iasonos A; Grisham RN; O'Cearbhaill RE; Tew WP; Long Roche K; Zivanovic O; Sonoda Y; Gardner GJ; Chi DS; Latham AJ; Carlo MI; Murciano-Goroff YR; Will M; Walsh MF; Robson ME; Mandelker DL; Berger MF; Abu-Rustum NR; Brown CL; Offit K; Hamilton JG; Aghajanian C; Weigelt B; Stadler ZK; Liu YL
JCO Precis Oncol; 2023 Sep; 7():e2300137. PubMed ID: 37738546
[TBL] [Abstract][Full Text] [Related]
5. Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
Kotecha RR; Knezevic A; Arora K; Bandlamudi C; Kuo F; Carlo MI; Fitzgerald KN; Feldman DR; Shah NJ; Reznik E; Hakimi AA; Carrot-Zhang J; Mandelker D; Berger M; Lee CH; Motzer RJ; Voss MH
Cancer; 2024 Mar; 130(5):692-701. PubMed ID: 37864521
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer risk and trends among distinct African descent populations.
Medina HN; Penedo FJ; Joachim C; Deloumeaux J; Koru-Sengul T; Macni J; Bhakkan B; Peruvien J; Schlumbrecht MP; Pinheiro PS
Cancer; 2023 Sep; 129(17):2717-2726. PubMed ID: 37357566
[TBL] [Abstract][Full Text] [Related]
7. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
Seagle HM; Keller SR; Tavtigian SV; Horton C; Holowatyj AN
J Clin Oncol; 2023 Sep; 41(26):4279-4289. PubMed ID: 37319387
[TBL] [Abstract][Full Text] [Related]
8. Germline drivers of gynecologic carcinosarcomas.
Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
[TBL] [Abstract][Full Text] [Related]
9. Family Recall of and Response to Germline Pathologic Variants Found on Paired Tumor-Germline Sequencing in Pediatric Oncology.
Jacobs MF; Goldman JW; Austin S; Koeppe ES; Murad AM; Koschmann CJ; Chinnaiyan AM; Mody RJ
JCO Precis Oncol; 2024 Mar; 8():e2300539. PubMed ID: 38484211
[TBL] [Abstract][Full Text] [Related]
10. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
[TBL] [Abstract][Full Text] [Related]
11. Association of specific PTEN/10q haplotypes with endometrial cancer phenotypes in African-American and European American women.
Sutton J; Orloff MS; Michener C; Chiesa-Vottero A; Prayson R; Nowacki AS; Eng C
Gynecol Oncol; 2015 Aug; 138(2):434-40. PubMed ID: 26026735
[TBL] [Abstract][Full Text] [Related]
12. The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study.
Rocconi RP; Lankes HA; Brady WE; Goodfellow PJ; Ramirez NC; Alvarez RD; Creasman W; Fernández JR
Gynecol Oncol; 2016 Feb; 140(2):264-9. PubMed ID: 26603970
[TBL] [Abstract][Full Text] [Related]
13. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
14. Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients.
Paixão D; Torrezan GT; Santiago KM; Formiga MN; Ahuno ST; Dias-Neto E; Tojal da Silva I; Foulkes WD; Polak P; Carraro DM
Front Oncol; 2022; 12():976959. PubMed ID: 36119527
[TBL] [Abstract][Full Text] [Related]
15. Disparities in adjuvant treatment of high-grade endometrial cancer in the Medicare population.
Corey L; Cote ML; Ruterbusch JJ; Vezina A; Winer I
Am J Obstet Gynecol; 2022 Apr; 226(4):541.e1-541.e13. PubMed ID: 34736911
[TBL] [Abstract][Full Text] [Related]
16. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
17. Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer.
Zheng S; Donnelly ED; Strauss JB
JAMA Netw Open; 2024 Jan; 7(1):e2351906. PubMed ID: 38231514
[TBL] [Abstract][Full Text] [Related]
18. Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center.
Chapman-Davis E; Zhou ZN; Fields JC; Frey MK; Jordan B; Sapra KJ; Chatterjee-Paer S; Carlson AD; Holcomb KM
J Gen Intern Med; 2021 Jan; 36(1):35-42. PubMed ID: 32720237
[TBL] [Abstract][Full Text] [Related]
19. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
20. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
Sung H; Wiese D; Jatoi I; Jemal A
JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
